Ossifying fibroma vs fibrous dysplasia of the jaw: Molecular and immunological characterization

Modern Pathology

Volumn 20, Issue 3, 2007, Pages 389-396

  Toyosawa, Satoru ^a   Yuki, Michiko ^a   Kishino, Mitsunobu ^a   Ogawa, Yuzo ^a   Ueda, Takafumi ^b   Murakami, Shumei ^a   Konishi, Eiichi ^c   Iida, Seiji ^a   Kogo, Mikihiko ^a   Komori, Toshihisa ^d   Tomita, Yasuhiko ^e  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA NATIONAL HOSPITAL   (Japan)

^c Department of Orthopedic Surgery   (Japan)

^d NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone matrix proteins; Differential diagnosis; Fibrous dysplasia; GNAS mutation; Ossifying fibroma; Runx2

Indexed keywords

ARGININE; BIOLOGICAL MARKER; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; OSTEOCALCIN; PEPTIDE NUCLEIC ACID; TRANSCRIPTION FACTOR RUNX2;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE DEVELOPMENT; CLINICAL ARTICLE; CODON; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FIBROBLAST; FIBROUS DYSPLASIA; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; JAW; JAW RADIOGRAPHY; MALE; MARKER GENE; MESENCHYMAL STEM CELL; MUTATIONAL ANALYSIS; OSSIFYING FIBROMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 33847374308     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800753     Document Type: Article

References (27)

1. Waldron CA. Fibro-osseous lesions of the jaws. J Oral Maxillofac Surg 1993;51:828-835.
2. Brannon RB, Fowler CB. Benign fibro-osseous lesions: a review of current concepts. Adv Anat Pathol 2001;8:126-143.
3. Alawi F. Benign fibro-osseous diseases of the maxillofacial bones. A review and differential diagnosis. Am J Clin Pathol 2002;118(Suppl):S50-S70.
4. Sciubba JJ, Fantasia JE, Kahn LB (eds). Fibro-osseous Lesions. AFIP Atlas of Tumor Pathology. Tumors and Cysts of the Jaw, 3rd Series, Fasc29 edn. Armed Forces Institute of Pathology: Washington, DC, 1999, pp 141-160.
5. Liens D, Delmas PD, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet 1994;343:953-954.
6. Kos M, Luczak K, Godzinski J, et al. Treatment of monostotic fibrous dysplasia with pamidronate. J Craniomaxillofac Surg 2004;32:10-15.
7. Greco MA, Steiner GC. Ultrastructure of fibrous dysplasia of bone: a study of its fibrous, osseous, and cartilaginous components. Ultrastruct Pathol 1986;10:55-66.
8. Riminucci M, Fisher LW, Shenker A, et al. Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol 1997;151:1587-1600.
9. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89:755-764.
10. Otto F, Thornell AP, Crompton T, et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997;89:765-771.
11. Weinstein LS, Shenker A, Gejman PV, et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991;325:1688-1695.
12. Malchoff CD, Reardon G, MacGillivray DC, et al. An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesion. J Clin Endocrinol Metab 1994;78:803-806.
13. Shenker A, Weinstein LS, Sweet DE, et al. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab 1994;79:750-755.
14. Alman BA, Greel DA, Wolfe HJ. Activating mutations of Gs protein in monostotic fibrous lesions of bone. J Orthop Res 1996;14:311-315.
15. Bianco P, Riminucci M, Majolagbe A, et al. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res 2000;15:120-128.
16. Zhang YW, Yasui N, Ito K, et al. A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci USA 2000;97:10549-10554.
17. Toyosawa S, Tomita Y, Kishino M, et al. Expression of dentin matrix protein 1 in tumors causing oncogenic osteomalacia. Mod Pathol 2004;17:573-578.
18. 201 mutations in G alphas from patients with fibrous dysplasia of bone. Bone 1997;21:201-206.
19. 201 codon: polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues. J Mol Diagn 2000;2:67-72.
20. Lietman SA, Ding C, Levine MA. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia. J Bone Joint Surg Am 2005;87:2489-2494.
21. Voytek TM, Ro JY, Edeiken J, et al. Fibrous dysplasia and cemento-ossifying fibroma. A histologic spectrum. Am J Surg Pathol 1995;19:775-781.
22. Sissons HA, Steiner GC, Dorfman HD. Calcified spherules in fibro-osseous lesions of bone. Arch Pathol Lab Med 1993;117:284-290.
23. Mark MP, Prince CW, Oosawa T, et al. Immunohistochemical demonstration of a 44-KD phosphoprotein in developing rat bones. J Histochem Cytochem 1987;35:707-715.
24. Hauschka PV, Lian JB, Gallop PM. Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci USA 1975;72:3925-3929.
25. Toyosawa S, Shintani S, Fujiwara T, et al. Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts. J Bone Miner Res 2001;16:2017-2026.
26. Ducy P, Desbois C, Boyce B, et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996;382:448-452.
27. Pimenta FJ, Gontijo Silveira LF, et al. HRPT2 gene alterations in ossifying fibroma of Tavares GC, the jaws. Oral Oncol 2006;42:735-759.